Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07321158
Eligibility Criteria:
Inclusion Criteria:
* diagnosis by neurologist with first damage of pyramidal tract with upper limb spasticity
* absence of cognitive dysfunction
* normal vital signs
* absence of pharmacological treatment of spasticity (per os pharmacological treatment does not affect spasticity results and was not an exclusion criteria on patients' recruitment).
Exclusion Criteria:
* prior neurological damage to pyramidal tract
* cognitive decline
* dermatological damages
* prior musculoskeletal dysfunction on the upper limb with spasticity
* presence of metallic residues on the spastic upper limb
* presence of seizures or psychiatric disorders
* severe malformation or obesity (BMI \>30kg/m2)
* history of coronary or other cardiovascular diseases (deep vein thrombosis, pulmonary embolism)
* presence of systematic inflammatory disease
* cancer on terminal stages
* pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07321158
Study Brief:
Protocol Section:
NCT07321158